Literature DB >> 15591580

The PROGRESS trial three years later: Clear and accurate interpretations of studies are needed.

Daniel G Hackam.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15591580      PMCID： PMC535467          DOI： 10.1136/bmj.329.7479.1404

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  The PROGRESS trial three years later: time for a balanced report of effectiveness.

Authors:  Richard Wennberg; Camilla Zimmermann
Journal:  BMJ       Date:  2004-10-23

2.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors: 
Journal:  Lancet       Date:  2001-09-29       Impact factor: 79.321

Review 3.  Progress in clinical neurosciences: pharmacotherapies for the secondary prevention of stroke.

Authors:  Daniel G Hackam; Moira K Kapral
Journal:  Can J Neurol Sci       Date:  2004-08       Impact factor: 2.104

4.  Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

Authors:  K M Fox
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.